• 1
    Bäckman L, Small BJ, Fratiglioni L. Cognitive deficits in preclinical Alzheimer's disease: current knowledge and future directions. In: DixonRA, BäckmanL, NilssonLG, eds. New Frontiers in Cognitive Aging. New York: Oxford University Press 2004; 161177.
  • 2
    Bäckman L, Small BJ, Fratiglioni L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain 2001; 124: 96102.
  • 3
    Albert MS, Moss MB, Tanzi R, Jones K. Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc 2001; 7: 6319.
  • 4
    Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995; 45: 31724.
  • 5
    Small BJ, Herlitz A, Fratiglioni L, Almkvist O, Bäckman L. Cognitive predictors of incident Alzheimer's disease: a prospective longitudinal study. Neuropsychology 1997; 11: 41320.
  • 6
    Linn RT, Wolf PA, Bachman DL et al. The ‘preclinical phase’ of probable Alzheimer's disease. Arch Neurol 1995; 52: 48590.
  • 7
    Fabrigoule C, Rouch I, Taberly A et al. Cognitive processes in preclinical phase of dementia. Brain 1998; 121: 13541.
  • 8
    Small BJ, Viitanen M, Bäckman L. Mini-Mental State Examination Scores as predictors of Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. J Gerontol Med Sci 1997; 52: 299304.
  • 9
    Elias MF, Beiser A, Wolf PA et al. The preclinical phase of Alzheimer's disease: a 22-year prospective study of the Framingham cohort. Arch Neurol 2000; 57: 80813.
  • 10
    La Rue A, Jarvik LF. Cognitive function and prediction of dementia in old age. Int J Aging Hum Dev 1987; 25: 7589.
  • 11
    Snowdon DA, Kemper SJ, Mortimer JA et al. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. JAMA 1996; 275: 52832.
  • 12
    Whalley LJ, Starr JM, Athawes R et al. Childhood mental ability and dementia. Neurology 2000; 55: 14559.
  • 13
    Tierney MC, Szalai JP, Snow WG et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 1996; 46: 6615.
  • 14
    Simons JS, Spiers HJ. Prefrontal and medial temporal lobe interactions in long-term memory. Nat Neurosci Rev 2003; 4: 63748.
  • 15
    Braak H, Braak E. Staging of Alzheimer disease-related neurofibrillary tangles. Neurobiol Aging 1995; 16: 27184.
  • 16
    Fox NC, Warrington EK, Freeborough PA et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. Brain 1996; 119: 20017.
  • 17
    Small SA, Perara G, DeLaPaz R, Mayeux R, Stern Y. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann Neurol 1999; 45: 46672.
  • 18
    Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Erlbaum, 1988.
  • 19
    Chen P, Ratcliff R, Belle SH, Cauley JA, DeKosky ST, Ganguli M. Patterns of cognitive decline in pre-symptomatic Alzheimer's disease: a prospective community study. Arch Gen Psychiatr 2001; 58: 8538.
  • 20
    Daly E, Zaitchik D, Copeland M, Schmahmann J, Gunther J, Albert M. Predicting conversion to Alzheimer's disease using standardized clinical information. Arch Neurol 2000; 57: 67580.
  • 21
    Fox NC, Warrington EK, Seiffer AL, Agnew SK, Rossor MN. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. Brain 1998; 121: 16319.
  • 22
    Convit A, Asis JD, Leon JJD, Tarshish CY, De-Santi S, Rusinek H. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging 2000; 21: 1926.
  • 23
    Grober E, Kawas C. Learning and retention in preclinial and early Alzheimer's disease. Psychol Aging 1997; 12: 1838.
  • 24
    Fowler KS, Saling MM, Conway EL, Semple JM, Louis WJ. Paired-associate performance in the early detection of DAT. J Int Neuropsychol Soc 2002; 8: 5871.
  • 25
    Howieson DB, Dame A, Camicioli R et al. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc 1997; 45: 5849.
  • 26
    Rubin EH, Storandt M, Miller JP et al. A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol 1998; 55: 395401.
  • 27
    Nielson H, Lolk A, Andersen K, Andersen J, Kragh-Sorensen P. Characteristics of elderly who develop Alzheimer's disease during the next two years – a neuropsychological study using CAMCOG. The Odense study. Int J Geriatr Psychiatr 1999; 14: 95763.
  • 28
    Smith GE, Bohac DL, Waring SC et al. Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer's disease but not in healthy control subjects. Neurology 1998; 50: 35562.
  • 29
    Lindeboom J, Schmand B, Tulner L, Walstra G, Jonker C. Visual association test to detect early dementia of the Alzheimer type. J Neurol Neurosurg Psychiatr 2002; 73: 12633.
  • 30
    Bozoki A, Giordani B, Heidebrink JL, Berent S, Foster NL. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol 2001; 58: 4116.
  • 31
    Palmer K, Bäckman L, Winblad B, Fratiglioni L. Detection of Alzheimer's disease and dementia in the preclinical phase: population-based cohort study. BMJ 2003; 326: 2457.
  • 32
    Bäckman L, Small BJ, Wahlin Å. Aging and memory: cognitive and biological perspectives. In: BirrenJE, SchaieKW, eds. Handbook of the Psychology of Aging, 5th edn. San Diego: Academic Press, 2001; 34977.
  • 33
    Park DC, Lautenschalger G, Hedden T et al. Models of visuospatial and verbal memory across the life span. Psychol Aging 2002; 17: 299320.
  • 34
    Salthouse TA. The processing-speed theory of adult age differences in cognition. Psychol Rev 1996; 103: 40328.
  • 35
    Bäckman L, Small BJ. Influences of cognitive support on episodic remembering: tracing the process of loss from normal aging to Alzheimer's disease. Psychol Aging 1998; 13: 26776.
  • 36
    Bäckman L, Laukka EJ, Wahlin Å, Small BJ, Fratiglioni L. Influences of preclinical dementia and impending death on the magnitude of age-related cognitive deficits. Psychol Aging 2002; 17: 43542.
  • 37
    Killiany RJ, Gomez-Isla T, Moss M et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 2000; 47: 4309.
  • 38
    Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JJ, Rossor MN. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic images. Lancet 2001; 358: 2015.
  • 39
    van der Flier WM, van den Heuvel DMJ, Weverling-Rijnsburger AWE et al. Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann Neurol 2002; 52: 627.
  • 40
    Kogure D, Matsuda H, Ohnishi T et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000; 41: 115562.
  • 41
    Arnáiz E, Jelic V, Almkvist O et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. NeuroReport 2001; 12: 8515.
  • 42
    Morris JC, Price JL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 2001; 17: 10118.
  • 43
    Yamaguchi H, Sugihara S, Ogawa A, Oshima N, Ihara Y. Alzheimer beta amyloid deposition enhanced by ApoE epsilon 4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects. J Neuropath Exp Neurol 2001; 60: 7319.
  • 44
    Wolf H, Ecke GM, Bettin S, Dietrich J, Gertz HJ. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatr 2000; 15: 80312.
  • 45
    Silverman DHS, Small GW, Chang CY et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 2001; 60: 7319.
  • 46
    van der Flier WM, van den Heuvel DMJ, Weverling-Rijnsburger AWE et al. Cognitive impairment in AD and mild cognitive impairment is associated with global brain damage. Neurology 2002; 59: 8749.
  • 47
    Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2000; 55: 184753.
  • 48
    Bondi MW, Salmon DP, Galasko D, Thomas R-G, Thal LJ. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychol Aging 1999; 14: 295303.
  • 49
    Hall CB, Lipton RB, Sliwinski M, Stewart WF. A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease. Stat Med 2000; 19: 155566.
  • 50
    Visser PJ, Verhey FRJ, Ponds RWHM, Jolles J. Diagnosis of preclinical Alzheimer's disease in a clinical setting. Int Psychogeriatr 2001; 13: 41123.
  • 51
    Jelic V, Johansson SE, Almkvist O et al. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging 2000; 21: 53340
  • 52
    Tabert MH, Albert SM, Borukhova-Milov L et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 2002; 58: 75864.
  • 53
    Hansen LA, De Teresa R, Davies P, Terry RD. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease. Neurology 1988; 38: 4854.
  • 54
    Mann DMA. Pathological correlates of dementia in Alzheimer's disease. Neurobiol Aging 1994; 15: 35760.
  • 55
    Korten AE, Henderson AS, Christensen H. et al. A prospective study of cognitive function in the elderly. Psychol Med 1997; 27: 91930.
  • 56
    Lindenberger U, Baltes PB. Intellectual functioning in old and very old age: cross-sectional results from the Berlin Aging Study. Psychol Aging 1997; 12: 41032.
  • 57
    Tierney MC, Szalai JP, Dunn E, Geslani D, McDowell I. Prediction of probable Alzheimer disease in patients with symptoms suggestive of memory impairment. Arch Fam Med 2000; 9: 52732.
  • 58
    Jacobsen MW, Delis DC, Bondi MW, Salmon DP. Do neuropsychological tests detect preclinical Alzheimer's disease: individual-test versus cognitive-discrepancy score analyses. Neuropsychology 2002; 16: 1329.
  • 59
    Riemenschneider M, Lautenschlager N, Wagenpfeil S et al. Cerebrospinal fluid tau and β-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch Neurol 2002; 59: 172934.
  • 60
    de Leon MJ, Golomb J, George AE et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. Am J Neuroradiol 1993; 14: 897906.
  • 61
    Tröster AI, Moe KE, Vitiello MV, Prinz PN. Predicting long-term outcome in individuals at risk for Alzheimer's disease with the Dementia Rating Scale. J Neuropsychiatr Clin Neurosci 1994; 6: 547.
  • 62
    Andreasen N, Minthon L, Vanmechelen E et al. Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment. Neurosci Lett 1999; 273: 58.
  • 63
    Small BJ, Fratiglioni L, Viitanen M, Winblad B, Bäckman L. The course of cognitive impairment in preclinical Alzheimer's disease: 3- and 6-year follow-up of a population-based sample. Arch Neurol 2000; 57: 83944.
  • 64
    Lindsay J, Laurin D, Verreault R et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002; 156: 44553.
  • 65
    Okamura N, Arai H, Maruyama M et al. Combined analyses of CSF tau levels and [(123)] iodoamphetamine SPECT in mild cognitive impairment: implications for a novel predictor of Alzheimer's disease. Am J Psychiatr 2002; 159: 4746.
  • 66
    Meyer JS, Xu G, Thornby J, Chowdhury M, Quach M. Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging. J Neurol Sci 2002; 201: 1925.
  • 67
    Tuokko H, Vernon-Wilkinson J, Weir J, Beattie BL. Cued recall and early identification of dementia. J Clin Exp Neuropsychol 1991; 13: 8719.
  • 68
    Helkala EL, Koivisto K, Hanninen T et al. Stability of age-associated memory impairment during a longitudinal population-based study. J Am Geriatr Soc 1997; 45: 1202.
  • 69
    Palmer K, Wang HX, Bäckman L, Winblad B, Fratiglioni L. Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project. Am J Psychiatr 2002; 159: 43642.
  • 70
    Devenand DP, Michaels-Marston KS, Liu X et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatr 2000; 157: 1399405.
  • 71
    Schaub RT, Anders D, Golz G, Gohringer K, Hellweg R. Serum nerve growth factor concentration and its role in the preclinical stage of dementia. Am J Psychiatr 2002; 159: 12279.
  • 72
    Bizdan L, Bizdan M. The predictive value of MMSE, ADAS-Cog, IADL, and PSMS as instruments for the diagnosis of preclinical phase of dementia of the Alzheimer type. Arch Psychiatr Psychother 2002; 2: 2534.
  • 73
    Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 3038.
  • 74
    Squire LR. Mechanisms of memory. Science 1986; 232: 16129.
  • 75
    Haist F, Gore JB, Mao H. Consolidation of human memory over decades revealed by functional magnetic resonance imaging. Nat Neurosci 2001; 4: 113945.
  • 76
    Craik FIM, McDowd JM. Age differences in recall and recognition. J Exp Psychol Learn Mem Cognit 1987; 13: 4749.
  • 77
    Jacoby LL, Toth JP, Yonelinas AP. Separating conscious and unconscious influences on memory: measuring recollection. J Exp Psychol Gen 1993; 122: 13954.
  • 78
    Craik FIM. On the transfer of information from temporary to permanent storage. Philos Trans R Soc Lond 1983; 302: 34159.
  • 79
    Hultsch DF, Hertzog C, Dixon RA, Small BJ. Memory Change in the Aged. Cambridge: Cambridge University Press, 1998.
  • 80
    Bäckman L, Small BJ, Wahlin Å, Larsson M. Cognitive functioning in very old age. In: CraikFIM, SalthouseTA, eds. Handbook of Aging and Cognition. Mahwah, NJ: Erlbaum, 1999.
  • 81
    Bäckman L, Jones S, Small BJ, Agüero-Torres H, Fratiglioni L. Rate of cognitive decline in preclinical Alzheimer's disease: the role of comorbidity. J Gerontol Psychol Sci 2003; 58: 22836.
  • 82
    Strauss E, MacDonald SWS, Hunter MA, Moll A, Hultsch DF. Intraindividual variability in cognitive performance in three groups of older adults: cross-domain links to physical status and self-perceived affect and beliefs. J Int Neuropsychol Soc 2002; 8: 893906.
  • 83
    Hultsch DF, MacDonald SWS, Hunter MA, Levy-Bencheton J, Strauss E. Intraindividual variability in cognitive performance in the elderly: comparison of adults with mild dementia, adults with arthritis, and healthy adults. Neuropsychology 2000; 14: 58898.
  • 84
    Farrer LA, Cupples LA, Haines JL et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA 1997; 278: 134956.
  • 85
    Geerlings MI, Jonker C, Bouter LM, Adèr HJ, Schmand B. Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition. Am J Psychiatr 1999; 156: 5317.
  • 86
    Berger A-K, Fratiglioni L, Forsell Y, Winblad B, Bäckman L. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 1999; 53: 19982002.
  • 87
    Launer LJ, Ross GW, Petrovitch H et al. Midlife blood pressure and dementia: The Honolulu-Asia aging study. Neurobiol Aging 2000; 21: 4955.
  • 88
    Plassman BL, Havlik RJ, Steffens DC et al. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 2000; 55: 115866.
  • 89
    Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer's disease: The Nun Study. JAMA 1997; 12: 8137.
  • 90
    Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B. Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet 2000; 355: 13159.
  • 91
    Hardy J, Allsop D. Amyloid deposition as the central event in the etiology of Alzheimer's disease. Trend Pharmacol Sci 1991; 12: 3838.
  • 92
    Jobst KA, Smith AD, Szatmari M et al. Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet 1994; 343: 82930.
  • 93
    Verhaeghen P, Marcoen A, Goossens L. Improving memory performance in the aged through mnemonic training: a meta-analytic study. Psychol Aging 1992; 7: 24251.
  • 94
    Cabeza R, Anderson ND, Locantore JK, McIntosh AR. Aging gracefully: compensatory brain activity in high-performing older adults. Neuroimage 2002; 17: 13942002.
  • 95
    Schmitt FA, Davis DG, Wekstein DR et al. ‘Preclinical’ AD revisited: neuropathology of cognitively normal older adults. Neurology 2000; 55: 3706.
  • 96
    DeKosky ST, Ikonomovic MD, Styren SD et al. Upregulation of choline acetyltransferase in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002; 51: 14555.
  • 97
    Hall CB, Ying J, Kuo L et al. Estimation of bivariate measurements having different change points, with application to cognitive aging. Stat Med 2001; 20: 3695714.
  • 98
    Wilson RS, Gilley DW, Bennett DA, Beckett LA, Evans DA. Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age. Psychol Aging 2000; 15: 1828.
  • 99
    Storandt M, Grant EA, Miller JP, Morris JC. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology 2002; 59: 103441.